Search by Drug Name or NDC

    NDC 00067-8137-20 Theraflu ExpressMax 325; 12.5; 5 mg/1; mg/1; mg/1 Details

    Theraflu ExpressMax 325; 12.5; 5 mg/1; mg/1; mg/1

    Theraflu ExpressMax is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 00067-8137
    Product ID 0067-8137_5201084d-a412-4c4f-b101-0432e97abd9f
    Associated GPIs 43994003900320
    GCN Sequence Number 060392
    GCN Sequence Number Description diphenhyd/phenyleph/acetaminop TABLET 12.5-5-325 ORAL
    HIC3 B3O
    HIC3 Description 1ST GEN ANTIHISTAMINE-DECONGESTANT-ANALGESIC COMB
    GCN 26540
    HICL Sequence Number 035433
    HICL Sequence Number Description DIPHENHYDRAMINE HCL/PHENYLEPHRINE HCL/ACETAMINOPHEN
    Brand/Generic Generic
    Proprietary Name Theraflu ExpressMax
    Proprietary Name Suffix Nighttime Severe Cold and Cough
    Non-Proprietary Name acetaminophen, diphenhydramine HCl, phenylephrine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 325; 12.5; 5
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 00067-8137-20 (00067813720)

    NDC Package Code 0067-8137-20
    Billing NDC 00067813720
    Package 2 BLISTER PACK in 1 CARTON (0067-8137-20) / 10 TABLET, FILM COATED in 1 BLISTER PACK
    Marketing Start Date 2016-07-05
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 62f7fcb9-e31a-4634-b1c2-44a9567e3a61 Details

    Revised: 6/2016